Leinco Technologies Inc., focuses on developing, manufacturing, and commercializing the highest purity antibodies (monoclonal, recombinant, and polyclonal), biologically active proteins and assays to enable scientists to generate reproducible science across a range of applications (pre-clinical studies, spatial biology, flow cytometry, & more).